Subcutaneous Panniculitis-Like T-Cell Lymphoma: A Case Report

Main Article Content

David Dayi Xiong
Brandon Tyler Beal
Manisha Manmohan
Maria Georgina Uberti
Kathryn Riley
Anthony Fernandez


cutaneous T-cell lymphoma, T-cell lymphoma, chemotherapy, cutaneous lymphoma


We present a case of a woman diagnosed with subcutaneous panniculitis-like T-cell lymphoma treated with prednisone and methotrexate with sustained symptom remission, suggesting that uncomplicated subcutaneous panniculitis-like T-cell lymphoma can be managed effectively without multiagent chemotherapy or radiation.


1. Willemze R, Jansen PM, Cerroni L, et al. Subcutaneous panniculitis-like T-cell lymphoma: definition, classification, and prognostic factors: an EORTC Cutaneous Lymphoma Group Study of 83 cases. Blood. 2008;111(2):838-845. doi:10.1182/blood-2007-04-087288

2. Parveen Z, Thompson K. Subcutaneous Panniculitis-like T-Cell Lymphoma: Redefinition of Diagnostic Criteria in the Recent World Health Organization–European Organization for Research and Treatment of Cancer Classification for Cutaneous Lymphomas. Arch Pathol Lab Med. 2009;133(2):303-308. doi:10.1043/1543-2165-133.2.303

3. Swerdlow S, Campo E, Harris N, Jaffe E, Pileri S, Stein H. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, Fourth Edition. Lyon, France: IARC; 2008.

4. Go RS, Wester SM. Immunophenotypic and molecular features, clinical outcomes, treatments, and prognostic factors associated with subcutaneous panniculitis-like T-cell lymphoma. Cancer. 2004;101(6):1404-1413. doi:10.1002/cncr.20502

5. Guenova E, Schanz S, Hoetzenecker W, et al. Systemic corticosteroids for subcutaneous panniculitis-like T-cell lymphoma. Br J Dermatol. 2014;171(4):891-894. doi:10.1111/bjd.13053